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Up to now, D-threo-tetrahydrobiopterin (DH4, dictyopterin) was detected only in Dictyostelium dis-
coideum, while the isomer L-erythro-tetrahydrobioterin (BH4) is common in mammals. To elucidate
the mechanism of DH4 regeneration by D. discoideum dihydropteridine reductase (DicDHPR), we
have determined the crystal structure of DicDHPR complexed with NAD+ at 2.16 Å resolution. Signif-
icant structural differences from mammalian DHPRs are found around the coenzyme binding site,
resulting in a higher Km value for NADH (Km = 46.51 ± 0.4 lM) than mammals. In addition, we have
found that rat DHPR as well as DicDHPR could bind to both substrates quinonoid-BH2 and quino-
noid-DH2 by docking calculations and have conﬁrmed their catalytic activity by in vitro assay.
Structured summary of protein interactions:
DHPR binds to DHPR by X-ray crystallography (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction hydroxylase (PAH) [11,13]. It was therefore presumed that D.Dihydropteridine reductase (DHPR; EC 1.5.1.34) catalyzes con-
version of quinonoid dihydrobiopterin (q-BH2) into L-erythro-tetra-
hydrobiopterin (BH4) during BH4 recycling [1]. DHPR dysfunction
in human is one of the causes of malignant hyperphenylalaninemia
due to BH4 deﬁciency [2]. BH4 is a well-known essential cofactor
for nitric oxide synthases [3] and aromatic amino acid hydroxy-
lases [4,5], which play vital roles in the biosynthesis of nitric oxide
and monoamine neurotransmitters, respectively. BH4 not only
exists in eukaryotes including mammals [6,7], but also in some
bacteria as glycosides [8–10]. BH4 is the most common form, but
other stereoisomers such as D-threo-BH4 (tetrahydrodictyopterin,
DH4) from Dictyostelium discoideum [11] and L-threo-BH4 from
Chlorobium tepidum [12] have also been detected.
Interestingly, DH4 and BH4 both exist in D. discoideum. The ma-
jor pterin in D. discoideum is dictyopterin with only traces of biop-
terin derivatives and DH4 is the better cofactor for phenylalaninechemical Societies. Published by E
biology, School of Medicine,
lic of Korea. Fax: +82 55 772
.kr (K.H. Lee).discoideum DHPR (DicDHPR) is able to reduce both quinonoid
(6R)-L-erythro-dihydrobiopterin (q-BH2) and quinonoid (6R)-D-
threo-dihydrobiopterin (q-DH2) back to BH4 and DH4, respectively,
using NADH as a coenzyme. The comparison of dictyopterin and
biopterin substrates by Physarum and sheep liver DHPR was
reported before [14]. DicDHPR has high protein sequence similari-
ties with the mammalian DHPRs (human DHPR: 57% similarity and
rat DHPR: 58% similarity) and Caenorhabditis elegans DHPR (64%
similarity). It implies that DicDHPR may share the same fold as
the homologous DHPRs in its cofactor and substrate binding sites
[15,16]. So, it is a question how the structurally similar DicDHPR
produces both BH4 and DH4. To elucidate this catalytic mechanism,
we have determined the structure of DicDHPR complexed with
NAD+ at 2.16 Å resolution.
Although the overall crystal structure of DicDHPR is similar to
other DHPR structures, a signiﬁcant structural change was
observed around the NAD(H)-binding pocket, which inﬂuences en-
zyme activity. Moreover, binding of substrates q-BH2 and q-DH2
into DicDHPR or rat DHPR was investigated further by docking cal-
culations. The docking results suggest that both DicDHPR and rat
DHPR could catalyze the conversion of q-DH2 as well as q-BH2.
These unknown activities of DicDHPR and rat DHPR were veriﬁedlsevier B.V. All rights reserved.
Table 1
Reﬁnement statistics of DicDHPR-NAD+.
DicDHPR-NAD+
Resolution range (Å) 50–2.16
Reﬂections used in the reﬁnement 46 917
Rwork/Rfreea (%) 18.50/24.01
No. of atoms 7040
No. of water molecules 149
No. of NAD molecules 4
Root mean square bonds (Å) 0.023
Root mean square bonds () 1.926
Average B factor (Å2)
Protein 41.08
Water molecules 36.32
NAD molecules 39.47
Ramachandran
Most favorable residues (%) 96.8
Allowed residues (%) 3.2
PDB codes 3ORF
a Rfree was calculated from a randomly chosen 5% of unique
reﬂections.
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insights into the relations between cofactor afﬁnity and catalytic
activity in DHPRs and also the catalytic mechanism of dual sub-
strate speciﬁcity to q-BH2 and q-DH2.
2. Materials and methods
2.1. Protein puriﬁcation, crystallization and data collection
The puriﬁcation, crystallization of theDicDHPR and theX-ray dif-
fraction data collection were following the protocols described pre-
viously [17]. In brief, DicDHPR was puriﬁed by nickel-afﬁnity,
cation-exchange and size-exclusion chromatography. Crystals of
DicDHPR-NAD+ were grown from 17% (w/v) Polyethylene glycol
3350 and 100 mM Bis–Tris at pH 6.5 by the hanging drop vapor
diffusionmethod. The crystal of aDicDHPR-NAD+complexdiffracted
to a resolution of 2.16 Å. The RatDHPRwas constructed into a vector
pET-28a, expressed and puriﬁed in the same way as the DicDHPR.
2.2. Structure determination and reﬁnement
The crystal structure of DicDHPR-NAD+ was determined by the
molecular replacement method as described before [17]. Then,
several cycles of manual model building and reﬁnement were per-
formed using the program O [18] and CNS [19]. Water molecules
were picked up from the Fo–Fc map on the basis of peak height
(>3r) and distance criteria (<3.5 Å). The ﬁnal model was reﬁned
using REFMAC5 [20] in CCP4 program suite and rebuilt by the
program COOT [21]. The quality of the ﬁnal model was validated
by PROCHECK [22]. Figures were prepared using PyMOL [23].
2.3. Docking
For the purpose of docking, only onemonomer ofDicDHPR in the
asymmetric unit was selected. All of the water molecules were
removed and hydrogens were added using the utility distributed
with AUTODOCK 4.2 [24]. For ligands, the substrates q-BH2 and
q-DH2 were generated by Dundee PRODRG2 Server [25]. The AUTO-
DOCKTOOLS program was used to generate the docking input ﬁles
using the implemented empirical free energy function and the
Lamarckian genetic algorithm. In all docking, a grid box size of
60  60  60 points in x, y and z directions was built and the maps
were centered on C4 atom of the NAD+molecule in the catalytic site
of the protein. All of the other docking parameters were used with
the default values according to the program manual. A hundred
independent docking runs were performed. Results within 0.5 Å
positional root mean-square deviations (RMSD) and with the most
favorable free energy of binding were selected and clustered to-
gether. Thebest docked conformationwas chosen tohave the lowest
binding energy in the cluster with the greatest number of members.
2.4. Cofactor activity assay
The reaction mixture contained 50 mM Tris–HCl, pH 7.5, 5 units
peroxidase, 0.004% H2O2, 0.1 mM BH4 and varying NADH. A 5 min
perincubation at 25 C, 2.8 lg enzyme was added to the cuvette
followed by mixing. The reaction mixture was incubated for
1 min at 25 C, and then the utilization of NADH in the reaction
mixture was spectrophotometrically determined at 340 nm based
on the oxidation of NADH [8,26].
2.5. Substrate speciﬁcity activity assay
DHPR activity was assayed by monitoring the oxidation of
NADH during the reduction of quinonoid isomer 6,7-dimethyldihy-dropterin to 6,7-dimethyltetrahydropterin [27,28], catalyzed by
DHPR. In the presence of H2O2, the pterin derivative 6,7-dimethyl-
tetrahydropterin was oxidized in situ by peroxidase to q-6,7-dim-
ethyldihydropterin and thus was recycled for the DHPR reaction.
The assay mixture contained 0.004% H2O2, 0.15 mM NADH, 5 units
peroxidase, 1 mM BH4 or DH4 and reaction buffer (50 mM Tris–HCl,
pH 7.5) in a ﬁnal volume of 700 ll (630 ll initial reaction
mixture + 70 ll enzyme solution added later). The initial mixture
without the enzyme was incubated for 5 min at 25 C and then
the reaction was initiated by adding the enzyme. The absorbance
of the samples and blanks (without enzyme) was measured at
340 nm after 5 min incubation at 25 C and before the enzyme
was added. Subsequently, 70 ll of puriﬁed enzyme (3 lg) solution
was added and mixed, and the absorbance was measured at the
same wavelength. The consumption of NADH was measured
against corresponding blanks at 340 nm for 5 min.
3. Results and discussion
3.1. Overall structure of DicDHPR-NAD+
The ﬁnal atomic model contains four molecules in the
asymmetric unit, and one NAD+ per molecule modeled. In the
Ramachandran plot, 96.8% of the residues were included in the
favored region, and all of the residues were in the allowed region.
A working R factor and R free values of the ﬁnal model are 18.50%
and 24.01%, respectively. The reﬁnement statistics are summarized
in Table 1.
In the DicDHPR-NAD+ binary structure, each chain (230 resi-
dues) has a modiﬁed a/b fold. An eight-stranded parallel b-sheet
in the center of the molecule is ﬂanked by 5 long a-helices and 3
short ones (Fig. 1A). There are 4 a-helices on each side of the
b-sheet. The overall structure of DicDHPR is similar to C. elegans
DHPR (CeDHPR), rat DHPR (RatDHPR) and human DHPR (HuDHPR)
with root mean square deviations (RMSD) of 1.2 Å to CeDHPR (PDB
code 1OOE) [29], 1.3 Å to RatDHPR (PDB code 1DHR) [15] and 1.4 Å
to HuDHPR (PDB code 1HDR) [16] among Ca atoms, calculated
with lsqkab in CCP4 Suite [30]. The largest differences are found
in three loop regions in DicDHPR with 4–6 Å shifts toward the
NADH binding site from other DHPRs (Fig. 1B).
Compared with mammalian DHPRs, DicDHPR has an additional
a-helix at the C-terminus like CeDHPR. The ﬁrst six-strands of the
b-sheet form a typical dinucleotide binding fold, an NAD(H)-bind-
ing Rossmann-like domain [31]. An NAD+ molecule is located on
Fig. 1. Overall structure of DicDHPR. (A) Stereoview of ribbon representation of the DicDHPR monomer. The NAD+ molecule bound to DicDHPR is shown in sticks. (B)
Superposition of the DHPR monomers from D. discoideumwith NADH (magenta), human (green; PDB code 1HDR, rat (cyan; PDB code 1DHR) and C. elegans (yellow; PDB code
1OOE). The largest differences are marked with black arrows.
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on both sides. The NAD+ molecule forms hydrogen bonds and Van
DerWaals interactions with surrounding residues as found in other
NAD(P)+-dependent dehydrogenases. In the asymmetric unit, there
exists a tetramer formed by two closely interacting DicDHPR-NAD+
dimers, in which the dimerization is facilitated by a four helix
motif or by the central b-sheets as in other DHPRs. However,
DicDHPR forms a dimer in solution as other DHPRs. Kinetic data
showed that dimeric DHPR has an enzyme activity and carries
out a chemical function [32,33]. In some DHPR deﬁciency patients,
mutation of tryptophan 108 (HuDHPR) located in dimer interface
to glycine was found, leading to 30–50% activity of a wild type
[33,34]. Some kinetic measurements found that changing trypto-
phan to phenylalanine is a more conservative substitution than
to glycine, as the ring structure is retained [35]. By contrast,
DicDHPR isoleucine 97 (the equivalent of Trp108 in HuDHPR) also
plays a part in this dimerization, interacting with Tyr101 and
stabilizing the dimer interface.
3.2. Comparison of the NADH binding site between DicDHPR and
mammalian DHPRs
In the DicDHPR-NAD+ binary structure, the NAD+ molecule has a
well-deﬁned electron density and occupies similar positions as in
mammalian DHPRs. The NAD+ molecule directly contacts with
the nearby residues via several well-deﬁned hydrogen bonds
(Fig. 2A). The nicotinamide ribose of NAD+ contacts throughhydrogen bonds to residues Tyr138 and Lys142 in an YXXXK
sequence frame. These two residues are well conserved in the fam-
ily of reductases and dehydrogenases [36]. From a close inspection
of the superimposed structure of DicDHPR-NAD+ over mammalian
DHPR-NADH structures, the segments of the main chain around
nicotinamide ring in DicDHPR-NAD+ slightly shifted by 1–2 Å away
from active site region.
The adenine ring of NAD+ is orientated with the re side face of
the Phe34 benzene ring in DHPRs. In contrast to mammalian
DHPRs, the loop (residues 47–50) between a2 and b2 shifted closer
by 6.67 Å toward to the NH2 group of adenine ring. Consequently,
several new contacts between the adenine ring of NAD+ and
DicDHPR are formed (Fig. 2A). The NH2 group is bounded by
residues Ser49 and Asp97 via hydrogen bonds. In DicDHPR-NAD+
complex, Arg35 instead of Val39 in RatDHPR and Val42 in HuDHPR,
interacts with NAD+ O3B by a distance of about 2.98 Å. The NAD+-
binding site of DicDHPR is affected by nearby residues Phe34,
Arg35, Ser49 and Asp97. As a result, the groove for the NAD+
adenine ring binding has a much narrower opening with a 5.37 Å
width than that of mammalian DHPR complex structures (7.54 Å
for RatDHPR; 8.51 Å for HuDHPR) (Fig. 2B). The surface of NAD+-
binding site in DicDHPR is a V-shaped channel with a 13.25 Å
depth. When compared with mammalian DHPR-NADH binary
structures, DicDHPR shows the smallest solvent accessible surface
area (SASA) for NAD+ (DicDHPR: 378.5 Å2; RatDHPR: 424.7 Å2;
HuDHPR: 443.9 Å2), suggesting that DicDHPR would exhibit the
lowest binding afﬁnity among them [37]. Furthermore, this
Fig. 3. Cofactor activity of DicDHPR. (A) Enzyme activity was measured with 0.1 mM BH4 and varying NADH concentration by monitoring the oxidation of NADH at 340 nm.
(B) Double-reciprocal plot of data presented in (A). Km value for NADH was 0.046 mM obtained from double-reciprocal plot.
Fig. 2. The NAD+ binding sites. (A) The superposition of the DicDHPR (pink), HuDHPR (pale green) and RatDHPR (pale cyan). The different residues for NAD+-binding are
shown as sticks (Residues in DicDHPR: carbon atoms in magenta, oxygen atoms in red, nitrogen atoms in blue; Residues in RatDHPR and HuDHPR: carbon atoms in green,
oxygen atoms in red, nitrogen atoms in blue). Hydrogen bonds between NAD+ molecule and the residues are shown in dashed lines (black). The shifts of loops in DicDHPR
from the positions in RatDHPR and HuDHPR are marked as a dashed arrow in red. (B) Comparison of the molecular surfaces of DicDHPR-NAD+ (a), RatDHPR-NADH (b) and
HuDHPR-NADH (c). The surface of DHPRs is colored in yellow. NAD(H) is represented by spheres (white, carbon atom; red, oxygen atom; blue, nitrogen atom). The distances
were measured between Phe34 and Asp97 in DicDHPR, Val38 and Lys105 in RatDHPR and Val41 and Lys108 in HuDHPR.
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higher Km value for NADH than mammals. To further investigate
NAD+-binding afﬁnity of DicDHPR, we have performed enzymatic
assay following the standard protocol [33]. In contrast to mamma-
lian DHPRs with the Km values of 11–13 lM for NADH [33,38],
DicDHPR carries apparent Km of 46.51 ± 0.4 lM (Fig. 3), supporting
that DicDHPR has a weaker enzyme activity for NADH. This seems
to be due to the different shape of the cofactor binding site with a
narrower cavity and a smaller buried surface area. The narrower
opening could make the entry and exit for NADH difﬁcult in
DicDHPR compared with the mammalian DHPRs, resulting in a
delayed cycle. Consequently, these structural differences in the
NADH binding site of DicDHPR may cause a different NADH-
binding mode, resulting in a weaker activity for NADH in DicDHPR.3.3. Analysis of substrate binding mode by docking
Since DicDHPR was found to catalyze the reduction of both qui-
nonoid q-BH2 and q-DH2, it was of interest to understand how
either q-BH2 or q-DH2 binds to the protein. Because of instability
of the substrates, it is not possible to get a stable DHPR complexed
with either of the stereoisomers. Therefore, we did docking calcu-
lations using AUTODOCK 4.2 and modeled both q-BH2 and q-DH2
into the DicDHPR-NAD+ binary structure to seek an explanation
for their binding mode.
The residues forming the substrate binding pocket are well con-
served among the DHPRs. The putative substrate binding pocket of
the DicDHPR is formed by two loops (loop I: residues 74–86, loop
II: residues 171–175) and one short a-helix (residues 136–153),
Fig. 4. Stereographic diagram of the proposed substrate binding mode. (A) The proposed models of q-DH2-DicDHPR-NAD+ and q-BH2-DicDHPR-NAD+ are displayed. (B) The
proposed models of q-DH2-RatDHPR-NADH and q-BH2-RatDHPR-NADH are displayed. Both the q-DH2 (carbon atoms in magenta, nitrogen atoms in blue, oxygen atoms in
red) and q-BH2 (carbon atoms in green, nitrogen atoms in blue, oxygen atoms in red) were docked at each of the active sites of DicDHPR and RatDHPR in the presence of NADH
(carbon atoms in gray, nitrogen atoms in blue, oxygen atoms in red). Potential hydrogen bonds are represented by dashed lines (magenta for q-DH2 and green for q-BH2) and
marked with distances.
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of the mammalian DHPRs. For this reason, the substrate binding
site in the DicDHPR is deeper and wider (depth 10.8 Å, width
12.5 Å) than that found in the RatDHPR (depth 9.6 Å, width
9.7 Å). Thus, this larger pocket of the DicDHPR may supply a much
broader chemical and physical environment for substrate binding
to DicDHPR.
The docking results showed that the binding mode of q-DH2 is
similar to that of q-BH2 with the well conserved residues around
the binding site and that the pteridine ring of q-BH2 and q-DH2
is positioned above in parallel to the nicotinamide of NAD+. Despite
the different conformation of hydroxyl groups between q-DH2 and
q-BH2, both substrates can make hydrogen bonds with the side
chain of Tyr138 and the main chain CO of Val171 (Fig. 4A). The
N5 of the pteridine ring in both substrates is close enough to
C40-carbonyl of NAD+ to form a hydrogen bond, as in the proposed
model of RatDHPR-NADH-q-BH2 [15]. Previous studies have
showed that the N5 of the pteridine could receive a hydride
[39,40]. According to our models obtained from the docking
calculations, the distance between the N5 of the pteridine and
the hydride of NADH is 3.91 Å and 3.81 Å to q-DH2 and q-BH2,
respectively, suggesting that the hydride can be directly trans-
ferred from the reduced nicotinamide ring to q-BH2 and q-DH2.3.4. q-DH2 catalysis by rat DHPR
Up to now, DH4 was only identiﬁed from vegetative cells of D.
discoideum [11]. So, it will be still interesting to know that other
DHPRs could also catalyze the conversion of q-DH2 into DH4. It
was shown before that Physarum and sheep liver DHPRs were able
to use various pteridine substrates and the Physarum enzyme had
higher selectivity for BH4 than DH4 [14]. To seek the possibility that
mammalian DHPRs carry the activity to use q-DH2 as a substrate
based on structural features, binding of q-BH2 and q-DH2 to the
RatDHPR was also examined by docking in the same way as to
DicDHPR. It showed that both substrates docked to similar binding
sites of RatDHPR as seen in DicDHPR, which suggests that RatDHPR
might also be able to catalyze the synthesis of DH4 from q-DH2 as
well as that of BH4 from q-BH2. To further investigate the possibil-
ity of q-DH2 catalysis to DH4, we have carried out the activity assay
for RatDHPR using q-DH2 (Fig. 5). The assay data unambiguously
revealed that RatDHPR has the activity to catalyze the conversion
of q-DH2 into DH4 as well as that of q-BH2 into BH4. Interestingly,
RatDHPR is found to carry higher enzyme activity than DicDHPR to
both substrates. Moreover, both RatDHPR and DicDHPR catalyze
q-DH2 conversion better than that of q-BH2. It also suggests that
DicDHPR and RatDHPR are able to distinguish the conﬁguration
Fig. 5. Speciﬁc activity assay for rat DHPR and DicDHPR. DicDHPR activity is
represented by black bars and RatDHPR activity by gray bars.
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analysis and activity assay with NADH as we discussed above,
RatDHPR has a deeper and wider NADH binding site and shows
lower Km value for NADH than DicDHPR. Considering the overall
similarities of the substrate binding site found in RatDHPR and
DicDHPR and the differences found around the NADH binding site
in RatDHPR, it seems that RatDHPR possesses a higher activity to
both substrates than DicDHPR in general due to more efﬁcient
exchange of NADH and higher hydride transfer rate.
From mutational studies, it has been shown that the hydrogen
transfer in this reductive process was strongly affected by the
Tyr-(Xaa)3-Lys motif in DHPR [36]. The residue tyrosine in the
active site (RatDHPR: Tyr146; DicDHPR: Tyr138) can make a
hydrogen bond with O4 of the pteridine that may initiate or com-
plete substrate catalysis. Therefore, any changes disturbing this
interaction would decrease the rate of hydride transfer. In the
RatDHPR and DicDHPR structures, the side chains of the tyrosine
and lysine in the Tyr-(Xaa)3-Lys motif were stacked together and
pointing toward the substrate binding site. In our models of Rat-
DHPR and DicDHPR with the substrates, the hydroxyl of tyrosine
(RatDHPR: Tyr146; DicDHPR: Tyr138) is positioned closely en-
ough to the O4 of both q-BH2 and q-DH2 to form a hydrogen
bond (Fig. 4A and B). This may be the reason why both the
DicDHPR and RatDHPR possess the activity toward both sub-
strates as the activity assay data shown (Fig. 5). However, we
could not ﬁnd any signiﬁcant structural information from the
models on the difference of speciﬁc activity between DH4 and
BH4.
In summary, mammalian DHPRs have been thought so far to
have strict stereospeciﬁcity to catalyze only q-BH2 conversion to
BH4. However, we show here for the ﬁrst time that RatDHPR as well
as DicDHPR can catalyze the conversion of q-DH2 in addition to
that of q-BH2.Acknowledgments
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